Neither rofecoxib nor naproxen slows cognitive decline in people with mild-to-moderate Alzheimer's disease

P. S. Aisen, K. A. Schafer, M. Grundman, David Knopman, Naji Tabet

Research output: Contribution to journalShort surveypeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)200-201
Number of pages2
JournalEvidence-based Healthcare
Issue number4
StatePublished - Jan 1 2003

ASJC Scopus subject areas

  • General Medicine

Cite this